NASDAQ:JAGX

Jaguar Health Stock Predictions

etoro logo Buy JAGX
*Your capital is at risk
$2.92
-0.300 (-9.32%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

JAGX Prediction Chart

JAGX Predictions History

Latest community submissions for JAGX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Dec 29, 2020 $0.799 -100.00% $0.720 X 88.97% 0
Dec 29, 2020 $0.700 -100.00% $0.720 V 97.28% 0
JS JS Pro
Dec 24, 2020 $0.96 -100.00% $0.715 V 66.43% 1
Zane Nguyen Zane Nguyen @ZaneNguyen.183670
Dec 24, 2020 Bullish $0.715 X 0
JS JS Pro
Dec 23, 2020 $0.407 -100.00% $1.07 X 38.04% 1
Chris Reeves Chris Reeves @ChrisReeves.170887
Dec 23, 2020 Bullish $1.07 X 1
JS JS Pro
Dec 18, 2020 $0.328 -100.00% $0.340 V 96.47% 1
Will Walker Will Walker @WillWalker.177039
Dec 18, 2020 Bullish $0.340 X 0
JS JS Pro
Dec 7, 2020 $0.339 -100.00% $0.405 V 83.62% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 13, 2020 $0.748 -100.00% $0.553 X 64.79% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for JAGX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT JAGUAR HEALTH, INC.
Jaguar Health
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE